Key result
Perioperative interventions, including beta-blockade, glucose management, and hemodynamics, are reviewed for their role in modifying cardiac risk and mortality during and after noncardiac surgery.
Why the study?
Do perioperative interventions modify the risk of morbidity and mortality in patients undergoing noncardiac surgery?
Do perioperative interventions modify the risk of morbidity and mortality in patients undergoing noncardiac surgery?
This review summarizes evidence from clinical trials on perioperative interventions to reduce cardiovascular morbidity and mortality during noncardiac surgery.
Anesthetic technique effects on perioperative cardiac risk remain uncertain; leaves open optimal choices pending higher-level trials.
Perioperative myocardial ischemia is the single most important, potentially reversible risk factor for mortality and cardiovascular complications during and after noncardiac surgery. The influence of anesthetic choices and techniques on cardiac risk in noncardiac surgery is difficult to ascertain because of the low incidence of morbid cardiac outcomes in the surgical population as a whole. This article summarizes several areas (eg, perioperative betablockade, glucose management, and perioperative hemodynamics) that have been addressed in well-designed clinical trials.
No takes yet. Share an insight, caveat, or question.
Reich et al. (2007) conducted a review in Perioperative myocardial ischemia in noncardiac surgery. Perioperative interventions (beta-blockade, glucose management, hemodynamics) was evaluated. Perioperative interventions, including beta-blockade, glucose management, and hemodynamics, are reviewed for their role in modifying cardiac risk and mortality during and after noncardiac surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: